A. Oszter et al., Regulation of activator protein-1-DNA binding activity by opioid peptides in estrogen-sensitive cells of rat hypothalamus and uterus, EUR J PHARM, 395(2), 2000, pp. 103-106
The present studies demonstrate, for the first time, that the binding of ac
tivator protein-1 (AP-1)-DNA in rat uterus and the estrogen-sensitive areas
of the hypothalamus, as measured by electrophoretic mobility shift assay,
is increased 2 h after intraperitoneal injection of [D-Met(2),Pro(5)]enkeph
alinamide. The effect was prevented by the opiate antagonist naltrexone giv
en 30 min before the administration of [D-Met(2),Pro(5)]enkephalinamide. su
ggesting the involvement of opioid peptide receptors in the observed effect
s. The present findings support the role of opioid peptides in the regulati
on of transcription in estrogen-sensitive cells. (C) 2000 Published by Else
vier Science B.V. All rights reserved.